Baxter International, Inc. (BAX)
23.80
-0.38
(-1.57%)
USD |
NYSE |
Sep 11, 16:00
23.81
+0.01
(+0.04%)
After-Hours: 20:00
Baxter International Enterprise Value : 18.98B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 18.98B |
| September 10, 2026 | 19.18B |
| September 09, 2026 | 19.29B |
| September 08, 2026 | 19.53B |
| September 04, 2026 | 20.03B |
| September 03, 2026 | 19.90B |
| September 02, 2026 | 19.97B |
| September 01, 2026 | 19.85B |
| August 31, 2026 | 20.12B |
| August 28, 2026 | 20.19B |
| August 27, 2026 | 20.09B |
| August 26, 2026 | 20.38B |
| August 25, 2026 | 20.27B |
| August 24, 2026 | 20.38B |
| August 21, 2026 | 20.30B |
| August 20, 2026 | 20.33B |
| August 19, 2026 | 20.45B |
| August 18, 2026 | 20.09B |
| August 17, 2026 | 20.08B |
| August 14, 2026 | 20.50B |
| August 13, 2026 | 20.66B |
| August 12, 2026 | 20.61B |
| August 11, 2026 | 20.95B |
| August 10, 2026 | 21.04B |
| August 07, 2026 | 20.92B |
| Date | Value |
|---|---|
| August 06, 2026 | 20.64B |
| August 05, 2026 | 20.81B |
| August 04, 2026 | 21.34B |
| August 03, 2026 | 21.21B |
| July 31, 2026 | 20.20B |
| July 30, 2026 | 20.51B |
| July 29, 2026 | 19.49B |
| July 28, 2026 | 19.28B |
| July 27, 2026 | 18.75B |
| July 24, 2026 | 18.26B |
| July 23, 2026 | 17.88B |
| July 22, 2026 | 17.92B |
| July 21, 2026 | 18.16B |
| July 20, 2026 | 18.09B |
| July 17, 2026 | 18.37B |
| July 16, 2026 | 18.75B |
| July 15, 2026 | 18.13B |
| July 14, 2026 | 17.95B |
| July 13, 2026 | 18.35B |
| July 10, 2026 | 18.37B |
| July 09, 2026 | 18.29B |
| July 08, 2026 | 18.04B |
| July 07, 2026 | 18.50B |
| July 06, 2026 | 18.35B |
| July 02, 2026 | 18.39B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 64.39B |
| DexCom, Inc. | 30.79B |
| Boston Scientific Corp. | 74.40B |
| West Pharmaceutical Services, Inc. | 24.26B |
| Abbott Laboratories | 204.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 135.00M |
| Revenue (Quarterly) | 2.96B |
| Total Expenses (Quarterly) | 2.825B |
| EPS Diluted (Quarterly) | 0.2432 |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 4.56% |
| Earnings Yield | -8.10% |
| Operating Earnings Yield | 5.26% |
| Normalized Earnings Yield | -1.729 |